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Abstract Tenascin-X (TNX) is a large, multi-domain,
extracellular matrix glycoprotein. Complete deficiency of
TNX in humans leads to a recessive form of Ehlers-Danlos
syndrome (EDS), and TNX haploinsufficiency is a cause of
hypermobility type EDS. EDS patients appear to have a
higher risk of several complications during pregnancy, such
as pelvic instability, premature rupture of membranes, and
postpartum hemorrhage. Here, we present a study of
genitourinary and obstetric complications in TNX-deficient
women of reproductive age. We have found complications,
such as uterus prolapses, that are in agreement with
previous findings in other EDS types. In TNX knockout
(KO) mice, we have observed mild pregnancy-related
abnormalities. Morphological and immunohistological anal-
ysis of uterine tissues has not revealed obvious quantitative
or spatial differences between TNX KO and wildtype mice
with respect to collagen types I, III, V, and XII or elastic
fibers. We conclude that TNX-deficient women are at risk
of obstetric complications, but that TNX KO mice show
only a mild phenotype. Furthermore, we show that TNX is
involved in the stability of elastic fibers rather than in their
initial deposition.
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Introduction
Tenascin-X (TNX) is a large, multi-domain, extracellular
matrix (ECM) glycoprotein composed of epidermal growth
factor (EGF) like-repeats, fibronectin type III repeats, and a
C-terminal fibrinogen domain (Bristow et al. 1993; Lethias
et al. 1996; Elefteriou et al. 1997; Ikuta et al. 1998; Tucker
et al. 2006). Complete deficiency of TNX in humans leads
to a rare recessive form of Ehlers-Danlos Syndrome (EDS),
and TNX haploinsufficiency is a cause of hypermobility
type EDS. Patients of both EDS types exhibit mild to
severe joint hypermobility. The skin of TNX-deficient
patients is markedly lax with poor recoil properties and
shows easy bruising. The collagen density appears reduced
in the dermis of these patients, and the elastic fibers are
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abnormal (Burch et al. 1997; Schalkwijk et al. 2001;
Zweers et al. 2003; Peeters et al. 2004; Lindor and Bristow
2005). Most of the literature concerning pregnancy in EDS
uses the old classification of nine subgroups. In our study,
we use the revised classification of six subtypes of EDS
(Beighton et al. 1998). Tissue fragility is a hallmark of EDS
and is present in all the different subtypes. EDS patients
appear to have a higher risk of several complications during
pregnancy, such as pelvic instability, premature rupture of
membranes, and postpartum hemorrhage. Pregnancy in
classical and hypermobility type EDS has a relative
favorable maternal and neonatal outcome. Pregnancy in
vascular type EDS patients is associated with severe
complications including maternal mortality (Pepin et al.
2000; Carley and Schaffer 2000; Roop and Brost 1999;
Wegrowski et al. 1999; Ramos-e-Silva et al. 2006; Lind and
Wallenburg 2002; Kuczkowski 2005; Parry and Strauss
1998). The effect of TNX deficiency on pregnancy has not
been studied so far, and only one case report of pregnancy
in a TNX-deficient woman has been reported in the
literature (Lindor and Bristow 2005). Here, we present a
study of all known pregnancies and genito-urinary (GU)
abnormalities in TNX-deficient woman of reproductive age
identified in our clinic (Schalkwijk et al. 2001) and in the
literature (Lindor and Bristow 2005; Schalkwijk et al.
2001). Furthermore, we have extended our studies to a
TNX knockout (KO) mouse model in which we have
investigated uterine development during pregnancy. We
have previously established that TNX is essential for the
development of tissue strength in the skin and is able to
bind to elastin, a major component of elastic fibers, and to
collagens type I, III, V, and XII (Egging et al. 2006a, b; Veit
et al. 2006). We have investigated the expression of these
molecules at the protein level.
Materials and methods
TNX-deficient patients
We investigated pregnancies and GU abnormalities in all
currently identified female tenascin-X deficient patients of
reproductive age identified in our clinic and in the
literature. The study protocol was approved by the local
medical ethics committee, and written informed consent
was obtained from the patients.
Experimental animals
TNX knockout (KO) mice were obtained as described
previously (Mao et al. 2002). For all studies, we used TNX
KO mice that were crossed back with six generations of
C57BL/6N mice. Wildtype C57BL/6 (WT) mice were used
as a control. All mice investigated for pregnancy abnor-
malities and morphological changes in uterus tissue were
between 2 and 6 months of age, reflecting a normal age
distribution of a breeding mice population. Skin samples
were taken from 2-month-old and 9-month-old mice, and
aortic tissue was obtained from 9-month-old mice. The
experimental design was approved by the Animal Use
Committee of Radboud University, Nijmegen.
Breeding
Breeding pairs were kept in a 5:1 female:male ratio. Females
were inspected daily for vaginal plugs, and those with plugs
were isolated and inspected each day for abnormalities and
progression of pregnancy. Litter size was determined after
birth. Neonatal survival is defined as the difference in litter
size after partus and 2 weeks postpartum.
Processing of samples for (immuno)histochemistry
Mice were killed in a sealed compartment by exposure to a
mixture of carbogen gas and increasing concentrations of
CO2. Skin samples for frozen sections were embedded in
Tissue-Tek O.C.T. compound (Sakura Finetek Europe, The
Netherlands) and snap frozen in liquid nitrogen. Skin
samples for paraffin sections were fixed in 4% buffered
formalin for 4 h.
Affinity-purified TNX antibody production
TNX FNIII repeats 27–32 were amplified by polymerase
chain reaction (PCR; forward primer: 5’-GGAATTCGAGC
TACCTCCCCAC-3’, reverse primer: 5’-CAGGTCGACT
CAGGTGAAAGAGGTGGA-3’) by using a previously
described 2.7-kb human TNX cDNA as a template (Morel
et al. 1989). The PCR product was ligated into the
pCR2.1TOPO vector (Invitrogen, Breda, The Netherlands)
according to the manufacturer’s instructions for easy
digestion with restriction enzymes. The pCR2.1 TOPO
vector with insert was digested with EcoRI and SalI. The
region coding for FNIII27-32 was inserted into the EcoRI/
SalI site of the pET28(a)+ plasmid (Brunschwig Chemie,
Amsterdam, The Netherlands). The sequence of the TNX
domains was verified by dideoxy sequencing with a 3730
DNA analyzer (Applied Biosystems, Nieuwekerk a/d IJssel,
The Netherlands). TNX FNIII27-32 protein was expressed
and purified according to the manufacturer’s instructions
(Brunschwig Chemie). Purified TNX FNIII27-32 protein
was used for immunization of a rabbit. Aliquots of 500 μg
TNX FNIII27-32 in 500 μl phosphate-buffered saline were
mixed with an equal volume of Freund’s complete adjuvant
for the first injection and Freund’s incomplete adjuvant for
boosters. Three injections were administered subcutaneously
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at 3-week intervals. Polyclonal antibodies against TNX
FNIII27-32 were purified by affinity chromatography on a
column with the antigen coupled to CNBr-activated sephar-
ose 4B (GE Healthcare Life Sciences, Diegem, Belgium).
Histopathology, histochemistry, and immunohistochemistry
Staining of elastic fibers was performed by modified Hart’s
stain on paraffin sections (7 μm; Starcher et al. 2005).
Paraffin sections were also stained with hematoxylin and
eosin (H&E) stain to assess uterus morphology and
pathology, in collaboration with a professional pathologist.
Frozen sections (7 μm) were stained with antibodies against
collagen types I, III, and V (SouthernBiotech, USA) and
elastin (Elastin Products, USA) as previously described by
Egging et al. (2006b). Collagen XII was stained as
previously described by Veit et al. (2006). TNX was stained
with affinity-purified antibodies directed against FNIII27-32
of TNX. Detection was performed with antibodies labeled
with fluorescein isothiocyanate (FITC, green; DakoCytoma-
tion, Denmark) and Alexa Fluor 594 (AF594, red; Molecular
Probes, The Netherlands). Cell nuclei were made visible with
4,6-diamidino-2-phenylindole (DAPI, blue; Molecular
Probes) counterstaining. Assesment of immunostaining was
performed as previously described (Egging et al. 2007,
2006b). Images were captured and processed with Axiovi-
sion software (Carl Zeiss, The Netherlands).
Electron microscopy
For electron microscopy, WT and TNX KO samples from
uterine wall at 3 weeks post-partum, skin from 2-month-old
and 9-month-old mice, and aortas from 9-month-old mice
were fixed in 3% glutaraldehyde in 0.1 M sodium
cacodylate overnight and washed in 0.1 M sodium
cacodylate buffer. The tissues were then sequentially treated
with osmium tetroxide, tannic acid, and uranyl acetate and
then dehydrated and embedded in Epon as previously
described (Davis 1993). Thin sections (60 nm) were
counterstained with 7% uranyl acetate in absolute methanol
and lead citrate and examined in a Tecnai 12 transmission
electron microscope, at 120 kV.
Statistics
For statistical analyses, Fisher’s exact or Chi-square tests
were used where appropriate for proportional data. Stu-
dent’s t-test was used to compare mean litter size after
partus and neonatal survival (difference in litter size after
partus and 2 weeks postpartum). A P-value of <0.05 was
considered statistically significant.
Table 1 Pregnancy in TNX-deficient woman (VUE vaginal uterine extirpation, IUD intra-uterine death, CAH congenital adrenal hyperplasia).






1 50 G1P1 None None
2 (sister of
patient 1)
60 G2P2 VUE after uterine prolapse (at age 49) None
Vaginal prolapse 2 weeks after VUE None
3 46 G0P0 None Was born prematurely (week 35) with
shoulder luxation, rectal prolapse at age 1
4 (sister of
patient 3)
51 G3P3 One incident of hemorrhage postpartum
(>1000 ml blood loss)
None
5 38 G0P0 None CAH
6 51 G3P2 IUD (24 weeks) with relatively large
blood loss
Deceased at age 51, severe co-morbidity
including cardiomyopathy, arrhythmia,
arteriosclerosis, and amputation of left leg
(Schalkwijk et al. 2001).
Undefined prolapse (at age 36)
7 57* G4P4 Precipitious second stage at term for all births Lindor and Bristow 2005
Uterine prolapse (at age 20), also recurrent
rectal prolapses
Table 2 Pregnancy in TNX-deficient mice
Genito-urinary complications TNX KO mice WT mice





Obstruction during partus 1 3
Excessive bleeding of vagina
(as seen at vaginal plug
check)
2 0
Cannibalism after partus 1 1
Total number of evaluated
pregnancies
36 31
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Results
Pregnancy in TNX-deficient patients
We investigated pregnancy and GU abnormalities in TNX-
deficient woman of reproductive age. General reproduction
characteristics and GU abnormalities of female TNX-
deficient patients are presented in Table 1. Maternal and
neonatal outcome was generally normal; one out of 13
pregnancies resulted in an intrauterine death of the fetus.
Tissue laxity of TNX-deficient patients was demonstrated
by the occurrence of vaginal, uterine, and rectal prolapses,
even at a relative young age. One case of postpartum
hemorrhage was observed in 12 childbirths. None of our
patients had urinary incontinence symptoms. TNX-deficient
EDS is an autosomal recessive disorder; therefore, all
offspring of a TNX-deficient patient and an unaffected
individual are obligatory heterozygotes. We have previous-
ly found that approximately 60% of adult females that are
haploinsufficient for TNX suffer from hypermobility type
EDS or benign joint hypermobility syndrome (Zweers et al.
2003). We found no obvious abnormalities (e.g. floppy
infant syndrome, premature birth) in the neonates (obliga-
tory heterozygotes) of our TNX-deficient population;
however, some TNX-deficient patients themselves were
born prematurely (Table 1; Lindor and Bristow 2005). Four
out of six of the TNX-deficient women had postpartum
complications (one of the patients had no pregnancies).
This was in agreement with the findings in the literature of
an increase in maternal GU complications in EDS-deficient
women compared with the control population (Ainsworth
and Aulicino 1993; Carley and Schaffer 2000; Kuczkowski
2005; Lind and Wallenburg 2002; Ramos-e-Silva et al.
2006).
Pregnancy in TNX KO mice
We investigated GU and pregnancy-related abnormalities in
TNX KO and WT mice ranging between 2–6 months of
age. Litter size (TNX KO: 7±2 pups, WT: 7±3 pups) and
neonatal survival (TNX KO: 74%±36%, WT: 54%±40%)
did not differ significantly (Student’s t-test). GU abnormal-
ities of the TNX KO and WT mice are presented in Table 2.
Overall, we noted relatively few pregnancy-related abnor-
malities. Obstruction of the uterine or vaginal canals during
partus resulting in a failure to deliver pups was noted more
often in WT mice compared with TNX KO mice, but the
difference was not significant (Chi-square test). The length
of term did not differ significantly for the TNX KO mice
(mean: 19.3 days) compared with WT mice (mean:
19.6 days, Fisher’s exact test). A striking difference,
however, between TNX KO and WT was found for the
location of the vaginal plug that was present after mating.
Generally, the vaginal plug in TNX KO mice was located
much deeper in the vaginal canal than in WT mice. This
made identification of vaginal plugs in TNX KO mice
markedly more difficult, resulting in a significant increase
in pregnancies with unknown length of pregnancy (Fig. 1a,
Chi-square test). No uterine or rectal prolapses were
observed in this particular study (67 pregnancies of KO
and WT mice). We did, however, observe rectal prolapses
in the breeding colony of our TNX KO mice population
(shown in Fig. 1b), albeit at a low frequency (<1%). We did
not observe rectal prolapses in our WT mice population.
Structure of mouse uterus
The mouse uterus consists of three layers: an outer layer,
which includes the single-cell layered perimetrium and a
thin layer of connective tissue; a muscular layer, the
myometrium, composed of two oppositely orientated layers
of muscle; and an endometrium, which undergoes remodel-
ing during the menstrual cycle and pregnancy. The
Fig. 1 TNX KO mice abnormalities. Vaginal plugs, which are present
after mating, are much more difficult to asses in TNX KO mice than in
WT mice. This resulted in a significant increase of pregnancies in
which the date of impregnation was unknown (a, *P<0.025, Chi-
square test). Total evaluations: TNX KO mice, n=32; WT mice, n=28.
In this study, no uterine prolapses were observed, although some TNX
KO mice suffered from a rectal prolapse (b). Rectal prolapses were
also observed in TNX-deficient patients, although the incidence in
TNX KO mouse was lower (<1% in mice)
Fig. 2 Structure of TNX KO and WT uterus. H&E-stained sections of
the uterus of WT mice (a) and of TNX KO mice (b). No differences in
the structure of the uteri were noticeable between TNX KO and WT
mice. The mouse uterus consists of a thin outer layer, the perimetrium
(P). A muscle layer, the myometrium (M), consists of two oppositely
orientated layers of muscle, although this is difficult to distinguish in
H&E-stained slides (E endometrium, L lumen). Bars 0.01 mm
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endometrium contains luminal and glandular epithelial
cells, stromal cells, resident immune cells of various types,
and endothelial cells. No differences in the overall
morphology of the uterine tissues were noticeable between
TNX KO and WT mice (Fig. 2; uteri on 1 day postpartum)
as assessed by light microscopy of H&E-stained sections.
As we mainly focused on the ECM compartment of the
uterus, we did not attempt to make quantitative analyses of
the cell type distribution.
TNX distribution in mouse uterus
TNX was present throughout the uterus of virgin mice and
in the uterus during and after pregnancy (Fig. 3a-c).
Immunostaining for TNX was discontinuous in the peri-
metrium (Fig. 3a-c,f). TNX was detected in the endometri-
um, although the epithelium lining the endometrium was
negative for TNX (Fig. 3d). Furthermore, TNX was present
in the layers of connective tissue ensheathing the muscle
bundles of the myometrium (Fig. 3f). Overall, no change in
the localization of TNX immunostaining was observed
during and after pregnancy. The specificity of our TNX
antibody was demonstrated by the complete absence of
positive staining in the tissues of the TNX KO mice
(Fig. 3e,g).
Collagen distribution in mouse uterus
We have previously demonstrated the binding and the
colocalization of TNX with collagen types I, II and V, in the
skin (Egging et al. 2006a, b). In the uterus, TNX also
colocalizes with major fibrillar collagens types I, III, and V,
as is shown for uteri 3 weeks postpartum (Fig. 4). The
collagens are present in the perimetrium, the endometrium,
and the layers of the connective tissue ensheathing the
muscle bundles of the myometrium. Similar results have
been obtained for uteri from virgin, 13-days pregnant, and
1-day postpartum mice. No differences in collagen type I,
III, and V immunostaining are found between WT and TNX
KO mice (data not shown), which is in agreement with our
Fig. 3 Immunostaining of TNX
in the uterus (P perimetrium, M
myometrium showing longitudi-
nal muscle bundles, M* myo-
metrium showing transverse
muscle bundles, E endometrium,
Epi epithelium of the lumen, L
lumen). TNX (green) is present
throughout the uterus of virgin
mice (a) and in the uterus during
and after pregnancy, shown for
uteri at 13 days pregnant (b) and
3 weeks postpartum (c). Cell
nuclei are stained with DAPI
(blue). TNX is present in the
endometrium (d) and the layers
of connective tissue ensheathing
muscle bundles of the myome-
trium (f). TNX immunostaining
of the perimetrium is relatively
weak (a-c, f). The epithelium of
the lumen is negative for TNX
(d). The specificity of the TNX
antibody is demonstrated in e, g.
d–g Uteri at 3 weeks postpar-
tum. Bars 50 μm
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observations in skin (Egging et al. 2006b). TNX does not
exclusively colocalize with collagens, however, because
TNX also cololalizes with other ECM components such as
(tropo)elastin. Collagen type XII, an interaction partner of
TNX (Veit et al. 2006), is present throughout the uterus
(Fig. 5). Collagen type XII occurs in the transverse muscle
bundles of the myometrium around blood vessels and
around the lumen, although the signal intensity is not
completely continuous around the lumen and blood vessels.
TNX and collagen type XII are both present throughout the
uterus. No differences in the collagen type XII localization
in the uterus between WT (Fig. 5a,c,e,g) and TNX KO
(Fig. 5b,d,f,h) mice have been observed.
Elastic fibers in mouse tissues
Elastic fibers in the skin of TNX-deficient patients are
known to be abnormally shaped (Zweers et al. 2004), and
Fig. 4 TNX colocalizes with major fibrillar collagens types I, III, and
V (P perimetrium, M myometrium with longitudinal muscle bundles,
M* myometrium with transverse muscle bundles, E endometrium, Epi
epithelium of the lumen, L lumen). TNX (b, e, h, green) and collagen
types I (a), III (d), and V (g, red) colocalize (c, f, i, yellow, orange,
magenta) in uteri 3 weeks postpartum. Similar results have been
obtained for uteri from virgin, 13-days pregnant, and 1-day postpar-
tum mice. No differences in collagen type I, III, and V immunostain-
ing are apparent between WT and TNX KO mice (data not shown). In
k, l, m, higher magnification images of the myometrium are shown to
demonstrate the colocalization of the fibrillar collagens with TNX
(collagen type III is used as an example). Bars 50 μm
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thus we have investigated their structure in TNX KO mouse
tissues. Elastic fibers in the uterus are mostly located in the
myometrium and perimetrium (Fig. 6a,b). The endometri-
um contains few elastic fibers as shown for WT (Fig. 6a)
and TNX KO (Fig. 6b) mice. In the myometrium and
perimetrium, positive staining for elastin is seen predomi-
nantly in the layers of connective tissue ensheathing the
transverse muscle bundles (Fig. 6c,d). Despite the relative
low abundance of mature elastic fibers in the endometrium,
the presence of elastin can be detected by immunohisto-
chemistry, possibly a consequence of the sensitivity of the
detection methods (Fig. 6c-d). Elastin localization is similar
for WT (Fig. 6c) and TNX KO (Fig. 6d) mice. We have
previously demonstrated binding of TNX with elastin and
the colocalization of these two proteins in skin (Egging
et al. 2006a, b). Consistent with these findings, elastin also
(partially) colocalizes with TNX in the uterus, as shown in
the myometrium (Fig. 6e). Colocalization of TNX with
elastin is not complete, since TNX also colocalizes with
fibrillar collagens; however, all elastin-reactive material
colocalizes with TNX. In previous work, we have showed
an increase in elastin-positive material in the skin of aging
TNX KO mice (Egging et al. 2006a, b). Although, by light
microscopy, the elastic fibers in the TNX KO mouse skin
do not appear to be abnormally shaped, an increase in
staining might have resulted from an increase in less mature
or less organized elastin fibers, an increase in soluble
tropoelastin within the matrix, and/or the consequence of
more immunoreactive epitopes being available because of
an increased susceptibility for degradation. These results
are consistent with our past observations of elastic fibers in
the skin of TNX-deficient patients in whom irregular and
immature elastic fibers and fibers devoid of microfibrils can
be seen at the ultrastructural level (Egging et al. 2006b;
Zweers et al. 2004). Thus, to expand these findings further
in skin and to investigate the elastic fibers in the uterus, we
have performed an ultrastructural analysis of the elastic
fibers in several tissues. Elastic fibers in WT (Fig. 7a) and
TNX KO mice (Fig. 7b) uteri do not appear to differ in
shape or size (shown for uterus 3 weeks postpartum).
Similarly, in aorta, the elastic laminae of WT (Fig. 7c) and
TNX KO mice (Fig. 7d) are similar in shape and number
(aorta of 9-month-old mice). In skin of older TNXKOmice
(as shown for 9-month-old mice), however, a difference in
elastic fiber ultrastructure is apparent compared withWTskin.
In addition to normal-appearing elastic fibers, irregular elastin
aggregates, as seen in the skin of TNX-deficient patients
(Zweers et al. 2004), can be observed (Fig. 7e,f). These
elastin aggregates are not found in the skin of 2-month-old
TNX KO mice or in 9-month-old WT mice. Interestingly,
elastic fibers in the skin of 9-month-old TNX KO mice often
appear larger than those of WT mice of the same age
(compare Fig. 7g,h).
Discussion
GU complications occur frequently in patients with various
types of EDS (Carley and Schaffer 2000; Ramos-e-Silva
et al. 2006; Lind and Wallenburg 2002; Kuczkowski 2005;
Parry and Strauss 1998; Pepin et al. 2000). In classical and
hypermobility types of EDS, which are the most common,
the outcome of pregnancy is generally favorable. Maternal
complications however, such as postpartum hemorrhage
and pelvic instability, are more common than in the general
population (Ramos-e-Silva et al. 2006; Kuczkowski 2005;
Parry and Strauss 1998). Furthermore, EDS patients appear
to have an elevated risk of uterine prolapse (Carley and
Schaffer 2000; Lind and Wallenburg 2002). Pregnancy in
Fig. 5 Immunostaining of collagen type XII in uterus (P perimetrium,
M myometrium with longitudinal muscle bundles, E endometrium).
Collagen XII (red) is present throughout the uterus. Immunostaining
appears to be the strongest in the transverse muscle bundles of the
myometrium (M*), around blood vessels (BV), and around the lumen
(L), although the signal intensity is not always completely continuous.
No differences in the collagen type XII localization in the uterus
between WT (a, c, e, g) and TNX KO (b, d, f, h) mice are observed.
Bars 50 μm
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patients with vascular type EDS may even lead to maternal
death through uterus or vessel rupture (Pepin et al. 2000).
We have investigated pregnancies and GU abnormalities in
TNX-deficient woman of reproductive age. Generally,
pregnancy is without major complications in TNX-deficient
patients, apart from one noted incident of postpartum
hemorrhage. However, uterine and vaginal prolapse regu-
larly occur in TNX-deficient women, even at a young age,
suggesting laxity of GU tissues. Premature rupture of fetal
membranes is a risk in pregnancy with EDS affected fetuses
(Lind and Wallenburg 2002; Parry and Strauss 1998). No
premature births have been observed in the offspring of the
TNX-deficient patients; however, some TNX-deficient
patients had been born prematurely. Obviously, some
caution must be taken in making conclusions and extrap-
olating data from such a small group of TNX-deficient
woman.
Complete TNX deficiency in humans is a rare condition,
and so far, only a few patients have been identified. We
have therefore investigated pregnancy and uterine tissue
structure in our TNX KO mouse model. No gross
significant differences have been found with regard to
abnormalities during pregnancy or reproduction between
the TNX KO and WT mice. A trend toward a reduction in
the length of pregnancy in TNX KO mice. The only
significant difference has been observed in the location of
the vaginal plugs, which suggests laxity in the vaginal wall.
In a previous study, we have not found any differences in
cutaneous collagen deposition between TNX KO and WT
mice (Egging et al. 2006b), as has been observed in the skin
of TNX-deficient patients (Schalkwijk et al. 2001; Zweers
et al. 2004). Alterations in collagen deposition in the skin of
TNX KO mice is, however, a matter of debate (Egging
et al. 2006b; Mao et al. 2002; Minamitani et al. 2004). In
the present study, we have found elastin aggregates and
enlarged elastic fibers in 9-month-old skin of TNX KO
mice at the ultrastructural level; this is in accordance with
our previously published data concerning increased elastin
staining in aging TNX KO mouse skin (Egging et al.
2006b). We have detected no differences in elastic fibers in
the uterus or elastic laminae of the abdominal aorta between
TNX KO and WT mice suggesting a specific role for TNX
in the maturation or maintenance of elastic fibers in skin.
However, abnormal elastic fibers might not be present in
the uterus, since the ECM is constantly being remodeled
during the menstrual cycle and pregnancy.
Although the TNX KO mice appear to have a much
milder phenotype compared with TNX-deficient humans,
the skin of TNX KO mice is significantly weaker and more
lax compared with WT mice (Bristow et al. 2005; Burch
Fig. 6 Elastin and elastic fibers in the uterus (L lumen). Elastic fibers
(purple, modified Hart’s staining) are mostly located in the myome-
trium (M, M*) and perimetrium (P), whereas the endometrium (E)
appears to contain fewer elastic fibers in WT (a) and TNX KO (b)
mice. No elastic fiber abnormalities are found in the TNX KO mice.
Elastin immunostaining (red) is observed in the myometrium,
predominantly in the transverse bundles (M* in c, d). The layers of
connective tissue ensheathing the muscle bundles of the myometrium
(M) and perimetrium (P) are stained positively for elastin (red). Strong
elastin staining is also seen in the endometrium (E). Elastin
immunoreactivity is similar for WT (c) and TNX KO (d) mice.
Elastin (red) colocalizes (orange) with TNX (green) in the myome-
trium (M* in e). Not all TNX colocalizes with elastin as TNX also
colocalizes with different collagen types (Fig. 4). Bars 50 μm
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et al. 1997; Egging et al. 2006b; Lindor and Bristow 2005;
Mao et al. 2002; Matsumoto et al. 2001; Minamitani et al.
2004; Schalkwijk et al. 2001; Zweers et al. 2004). Our data
suggest a more lax vaginal canal in TNX-deficient patients
and to a certain degree in TNX KO mice. An attractive
speculation, considering the observations from our studies
in mice, is that TNX is essential for tissue integrity,
independent of the quantity of collagen deposition or elastic
fiber structure. In conclusion, we would advise obstetricians
and gynecologists to monitor TNX-deficient patients
closely, as they are likely to have weaker GU connective
tissue and could therefore be at risk of GU complications.
Fig. 7 Ultrastructural evalua-
tion of elastic fibers. Elastic
fibers in WT (a) and TNX KO
(b) mouse uterus do not appear
to differ in shape or size. The
dark structures (arrows) are
elastic fibers (shown for uterus
at 3 weeks postpartum). The
elastic laminae (arrows) in the
aorta of WT (c) and TNX KO
(d) mice are similar in shape and
number (aorta of 9-month-old
mice). Skin of older TNX KO
mice (9 months old) shows
differences in elastic fibers from
those of WT skin. Irregular
elastin aggregates can be ob-
served in the TNX KO mouse
skin (e, near a sebaceous gland).
A higher magnification of an
elastin aggregate (arrow) is
shown in f. These aggregates
were not found in skin of 2-
month-old TNX KO mice or in
9-month-old WT mice. No ir-
regularities in the shape of
elastic fibers are observed in 9-
month-old TNX KO mice skin;
however, larger elastic fibers
than in WT mice (g) are often
observed in the TNX KO mice
(h, arrows elastic fibers). Bars
0.5 μm (a, b), 10 μm (c, d),
2 μm (e, g, h), 1 μm (f)
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